Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 30 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
KRASG12D-driven Pentose Phosphate Pathway Remodeling Imparts a Targetable Vulnerability Synergizing with MRTX1133 for Durable Remissions in PDAC
Xiangyan Jiang, Tao Wang, Bin Zhao, Haonan Sun,Yuman Dong, Yong Ma, Zhigang Li, Yuxia Wu,Keshen Wang,Xiaoying Guan,Bo Long,Long Qin,Wengui Shi,Lei Shi,Qichen He, Wenbo Liu, Mingdou Li, Lixia Xiao, Chengliang Zhou,Hui Sun,Jing Yang,Junhong Guan,Huinian Zhou,Zeyuan Yu,Zuoyi Jiao
Cell reports Medicineno. 2 (2025): 101966-101966
Cited0Views0WOSBibtex
0
0
Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy
Zongrui Xing,Xiangyan Jiang, Yuxia Wu,Zeyuan Yu
Current Cancer Drug Targets (2024)
Cited0Views0WOSBibtex
0
0
Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms
Yuxia Wu,Xiangyan Jiang,Zeyuan Yu, Zongrui Xing,Yong Ma, Huiguo Qing
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2024)
Cited0Views0WOSBibtex
0
0
Targeting the Mevalonate Pathway Enhances the Efficacy of 5-Fluorouracil by Regulating Pyroptosis
Zongrui Xing,Yong Ma,Xiangyan Jiang, Huiguo Qing, Yuxia Wu, Shengfu Che, Zhongti Gao,Keshen Wang,Tao Wang,Qichen He, Zhigang Li, Bin Zhao, Wenbo Liu,Haonan Sun,Zeyuan Yu
Medical oncology (Northwood, London, England)no. 1 (2024): 9-9
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 30

#Citation: 359

H-Index: 10

G-Index: 17

Sociability: 5

Diversity: 2

Activity: 12

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn